To access the full text documents, please follow this link: http://hdl.handle.net/2445/135141
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Ejaz, Asma |
dc.contributor.author | Martinez-Guino, Laura |
dc.contributor.author | Goldfine, Allison B. |
dc.contributor.author | Ribas Aulinas, Francesc |
dc.contributor.author | De Nigris, Valeria |
dc.contributor.author | Ribó Gené, Sílvia |
dc.contributor.author | González Franquesa, Alba |
dc.contributor.author | García-Roves, Pablo M. (Pablo Miguel) |
dc.contributor.author | Li, Elizabeth |
dc.contributor.author | Dreyfuss, Jonathan M. |
dc.contributor.author | Gall, Walt |
dc.contributor.author | Kim, Jason K. |
dc.contributor.author | Bottiglieri, Teodoro |
dc.contributor.author | Villarroya i Gombau, Francesc |
dc.contributor.author | Gerszten, Robert E. |
dc.contributor.author | Patti, Mary-Elizabeth |
dc.contributor.author | Lerín Martínez, Carlos |
dc.date | 2019-06-14T14:51:18Z |
dc.date | 2019-06-14T14:51:18Z |
dc.date | 2016-04 |
dc.date | 2019-06-14T14:51:18Z |
dc.identifier.citation | 0012-1797 |
dc.identifier.citation | 657103 |
dc.identifier.uri | http://hdl.handle.net/2445/135141 |
dc.format | 11 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | American Diabetes Association |
dc.relation | Reproducció del document publicat a: https://doi.org/10.2337/db15-1094 |
dc.relation | Diabetes, 2016, vol. 65, num. 4, p. 902-912 |
dc.relation | https://doi.org/10.2337/db15-1094 |
dc.rights | cc-by-nc-nd (c) American Diabetes Association, 2016 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/es |
dc.subject | Betaïna |
dc.subject | Farmacologia |
dc.subject | Fibroblasts |
dc.subject | Factors de creixement |
dc.subject | Sang |
dc.subject | Glucosa |
dc.subject | Metabolisme |
dc.subject | Efectes secundaris dels medicaments |
dc.subject | Fetge |
dc.subject | Betaine |
dc.subject | Pharmacology |
dc.subject | Fibroblasts |
dc.subject | Growth factors |
dc.subject | Blood |
dc.subject | Glucose |
dc.subject | Metabolism |
dc.subject | Drug side effects |
dc.subject | Liver |
dc.title | Dietary betaine supplementation increases Fgf21 levels to improve glucose homeostasis and reduce hepatic lipid accumulation in mice |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |